Laura E. Laróvere

855 total citations
17 papers, 540 citations indexed

About

Laura E. Laróvere is a scholar working on Molecular Biology, Clinical Biochemistry and Infectious Diseases. According to data from OpenAlex, Laura E. Laróvere has authored 17 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Clinical Biochemistry and 6 papers in Infectious Diseases. Recurrent topics in Laura E. Laróvere's work include Biochemical and Molecular Research (8 papers), Metabolism and Genetic Disorders (7 papers) and HIV/AIDS drug development and treatment (5 papers). Laura E. Laróvere is often cited by papers focused on Biochemical and Molecular Research (8 papers), Metabolism and Genetic Disorders (7 papers) and HIV/AIDS drug development and treatment (5 papers). Laura E. Laróvere collaborates with scholars based in Argentina, Spain and United States. Laura E. Laróvere's co-authors include Raquel Dodelson de Kremer, Irène Ceballos-Picot, David J. Schretlen, Rosa J. Torres, Juan Puig, William L. Nyhan, Jasper E. Visser, Hyder A. Jinnah, Stephen G. Reich and James C. Harris and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Frontiers in Immunology.

In The Last Decade

Laura E. Laróvere

16 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura E. Laróvere Argentina 8 387 213 147 75 66 17 540
G. Jacomelli Italy 12 247 0.6× 131 0.6× 70 0.5× 37 0.5× 24 0.4× 28 324
Emmanuel Scalais Belgium 14 314 0.8× 163 0.8× 144 1.0× 55 0.7× 145 2.2× 30 762
Takayuki Ishige Japan 12 191 0.5× 57 0.3× 127 0.9× 29 0.4× 48 0.7× 49 575
E. Arnaudo Italy 4 436 1.1× 97 0.5× 166 1.1× 34 0.5× 334 5.1× 4 668
Mitsuo Toyoshima Japan 9 78 0.2× 30 0.1× 62 0.4× 19 0.3× 43 0.7× 24 253
Jenny D. Jokinen United States 13 117 0.3× 146 0.7× 123 0.8× 34 0.5× 18 0.3× 16 483
Lawrence Greed Australia 9 96 0.2× 102 0.5× 72 0.5× 63 0.8× 54 0.8× 15 373
Stefanos A. Kalamidas Greece 14 192 0.5× 317 1.5× 86 0.6× 108 1.4× 7 0.1× 21 592
Iryna Kamyshna Ukraine 11 158 0.4× 67 0.3× 88 0.6× 25 0.3× 6 0.1× 42 351
Satomi Hashimoto Japan 12 217 0.6× 100 0.5× 63 0.4× 25 0.3× 12 0.2× 25 545

Countries citing papers authored by Laura E. Laróvere

Since Specialization
Citations

This map shows the geographic impact of Laura E. Laróvere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Laróvere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Laróvere more than expected).

Fields of papers citing papers by Laura E. Laróvere

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. Laróvere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Laróvere. The network helps show where Laura E. Laróvere may publish in the future.

Co-authorship network of co-authors of Laura E. Laróvere

This figure shows the co-authorship network connecting the top 25 collaborators of Laura E. Laróvere. A scholar is included among the top collaborators of Laura E. Laróvere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura E. Laróvere. Laura E. Laróvere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Häberle, Johannes, et al.. (2022). Immune Alterations in a Patient With Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome: A Case Report. Frontiers in Immunology. 13. 861516–861516. 3 indexed citations
2.
Laróvere, Laura E., Lynette D. Fairbanks, Hyder A. Jinnah, et al.. (2021). Lesch-Nyhan Disease and Its Variants: Phenotypic and Mutation Spectrum of Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency in Argentine Patients. SHILAP Revista de lepidopterología. 9.
3.
Kremer, Raquel Dodelson de, et al.. (2020). Efficacy of citrulline supplementation to decrease the risk of pulmonary hypertension after congenital heart disease surgery. A local experience.. SHILAP Revista de lepidopterología. 77(4). 249–253. 4 indexed citations
4.
Arranz, José Antonio, et al.. (2019). Urea cycle disorders in Argentine patients: clinical presentation, biochemical and genetic findings. Orphanet Journal of Rare Diseases. 14(1). 203–203. 5 indexed citations
5.
Laróvere, Laura E., et al.. (2018). Mutation Spectrum and Genotype–Phenotype Correlation in a Cohort of Argentine Patients with Ornithine Transcarbamylase Deficiency: A Single-Center Experience. SHILAP Revista de lepidopterología. 6. 4078293477–4078293477. 7 indexed citations
6.
Fu, Rong, Irène Ceballos-Picot, Rosa J. Torres, et al.. (2013). Genotype–phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. Brain. 137(5). 1282–1303. 89 indexed citations
7.
8.
Fu, Rong, Laura E. Laróvere, Rosa J. Torres, et al.. (2010). Mechanisms for phenotypic variation in Lesch–Nyhan disease and its variants. Human Genetics. 129(1). 71–78. 17 indexed citations
9.
Ceballos-Picot, Irène, Rosa J. Torres, Jasper E. Visser, et al.. (2010). Attenuated variants of Lesch-Nyhan disease. Brain. 133(3). 671–689. 105 indexed citations
11.
Laróvere, Laura E., John P. O’Neill, Matthew J. Randall, et al.. (2007). Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency: Biochemical and Molecular Findings in Six Argentine Patients. Nucleosides Nucleotides & Nucleic Acids. 26(3). 255–258. 5 indexed citations
12.
Jinnah, Hyder A., Jasper E. Visser, James C. Harris, et al.. (2006). Delineation of the motor disorder of Lesch–Nyhan disease. Brain. 129(5). 1201–1217. 171 indexed citations
13.
Becerra, M. C., Paulina L. Páez, Laura E. Laróvere, & Inés Albesa. (2006). Lipids and DNA oxidation in Staphylococcus aureus as a consequence of oxidative stress generated by ciprofloxacin. Molecular and Cellular Biochemistry. 285(1-2). 29–34. 49 indexed citations
14.
Laróvere, Laura E., Nuria M. Romero, Lynette D. Fairbanks, et al.. (2004). A novel missense mutation, c.584A>C (Y195S), in two unrelated Argentine patients with hypoxanthine–guanine phosphoribosyl-transferase deficiency, neurological variant. Molecular Genetics and Metabolism. 81(4). 352–354. 6 indexed citations
15.
Laróvere, Laura E., et al.. (2003). Genetic polymorphism of thiopurine S-methyltransferase in Argentina. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 40(4). 388–393. 44 indexed citations
16.
Latini, Alexandra, Laura E. Laróvere, & Raquel Dodelson de Kremer. (2002). Purines, Lactate and Myo-Inositol in CSF Might Reflect Excitotoxicity in Inherited Metabolic Disorders. Advances in experimental medicine and biology. 486. 91–95. 1 indexed citations
17.
Kremer, Raquel Dodelson de, Alexandra Latini, Terttu Suormala, et al.. (2002). Leukodystrophy and CSF Purine Abnormalities Associated with Isolated 3-Methylcrotonyl-CoA Carboxylase Deficiency. Metabolic Brain Disease. 17(1). 13–18. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026